WILLIAM TILLMAN: Open Payments
NPI 1609397686 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 12 payments from 8 companies in 2025. Trend: 2023 $213 · 2024 $265 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Tris Pharma Inc | 2 | $33 |
| Alkermes, Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Corium, LLC | 2 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Photrexa Viscous and Photrexa, COBENFY, Dyanavel XR, VIVITROL, SPRAVATO, Azstarys, Relexxii, ABILIFY ASIMTUFII.
Industry payments across AL — which companies pay providers there.
